(1)
A Review: Oral Lumbrokinase As Potential Agent Prevents Myocardial Reinfarction Post-Reperfusion in ST-Elevation Myocardial Infarction (STEMI) Patients. SCRIPTA SCORE Sci Med J. 2024, 5 (2), 121-131. https://doi.org/10.32734/scripta.v5i2.15156.